Editorial: The self-renewal and reprogramming of cancer stem cells and their crosstalk with the immune microenvironment

Front Cell Dev Biol. 2022 Nov 11:10:1024761. doi: 10.3389/fcell.2022.1024761. eCollection 2022.

Chong Li^{1

2}, Jayanth Kosagisharaf Rao³, Lakshmi Sowmya Emani⁴, Rao Jagannatha Kosagisharaf^{4

5}, Muralidhar L Hegde^{6

7}

¹ Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
² Zhongke Jianlan Medical Research Institute, Beijing, China.
³ Graduate Medical Student, University College of Dublin Medical School, Dublin, Ireland.
⁴ Department of Biotechnology, Koneru Lakshmaiah Education Foundation, Vaddeswaram, India.
⁵ National Science System (SNI), SENACYT, Clayton, City of Knowledge, Panama.
⁶ Division of DNA Repair Research, Center for Neuroregeneration, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX, United States.
⁷ Department of Neurology, Weill Medical College of Cornell University, New York, NY, United States.

No abstract available

Keywords: cancer; drug discovery; mRNA; mechanism; prevention; reprogramming.

Publication types